Covers Alzheimer’s disease, cardiometabolic disorders, neurological disorders, diabetes, cancer variants, cardiac variants and other rare variants.
- Genome-wide association study (GWAS) imputation module with >540,000 markers
from South and East Asian populations
- Covers >43,000 pathogenic or likely pathogenic associations from ClinVar archives
- Covers >9,000 immune-related markers (human leukocyte antigen, killer
immunoglobulin-like receptors, autoimmune, and inflammatory)
- Comprises >910 markers associated with increased risk for neurological conditions
- Comprises >43,000 markers to detect genetic changes that are predicted to
completely disrupt the function of protein-coding genes
- Comprises >400 Markers on the Y chromosome that are suitable for applications
covering deep ancestry
- Exclusive markers >2,000 Established markers known to be of high clinical
importance such as those in BRCA1, BRCA2, CFTR, DMD, and APOE genes (with
>78% GC content in flanking sequences)
- Covers >500 Common mitochondrial DNA variants
The array can be customized with 50,000 markers without affecting the imputation
accuracy, or it can be fully customizable as required.
